Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated CoagulopathyJean‐Louis Vincent, Jean-Baptiste Lascarrou, М. Yu. Кirov et al.|JAMA|2019Cited by 370
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic ShockPierre‐François Laterre, Scott Berry, Allan Blemings et al.|JAMA|2019Cited by 141
Recombinant Human Superoxide Dismutase Enhances the Effect of Inhaled Nitric Oxide in Persistent Pulmonary HypertensionRobin H. Steinhorn, Jonathan M. Davis, George Albert et al.|American Journal of Respiratory and Critical Care Medicine|2001Cited by 93
The Central Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Septic Pathogen Lipid Transport and ClearanceKeith R. Walley, John H. Boyd, Gordon A. Francis et al.|American Journal of Respiratory and Critical Care Medicine|2015Cited by 59
Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock—Adaptive Clinical TrialRoger Lewis, Scott Berry, Derek C. Angus et al.|Annals of the American Thoracic Society|2018Cited by 44